4 withdrawn. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 4 |
| Phase 2 | 2 | Withdrawn 2 |
Follow B-cell Lymphoma: new trials by email Literature Review of B-cell Lymphoma trials Research Report on B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma Triple-targeted CAR-T Therapy - B-cell Lymphoma | Phase 1 | Withdrawn | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2024-11-07 | 2026-05-06 | |
| Anti-CD19 Universal CAR-NK Cells Therapy Combined With HSCT for B Cell Hematologic Malignancies anti-CD19 UCAR-NK cells - B-cell Lymphoma, B-cell Leukemia | Phase 1 / Phase 2 | Withdrawn | Kunming Hope of Health Hospital | 2022-10-01 | 2022-11-30 | |
| CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL Fast Dual CAR-T Injection - B-cell Lymphoma | Phase 1 | Withdrawn | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-05-05 | 2023-02-10 | |
| Interleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell Malignancies 4SCAR19/22 T cells, Interleukin-2 - B-Cell Leukemia, B-Cell Lymphoma | Phase 1 / Phase 2 | Withdrawn | Zhujiang Hospital | 2017-12-30 | 2024-03-18 |
Lymphoma, B-Cell (4) · Leukemia, B-Cell (2) · Fasting (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoma (4) · Lymphoma, Non-Hodgkin (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Hematologic Diseases (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Behavior (1) · Feeding Behavior (1)
Interleukin-2 (1)
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1) · Kunming Hope of Health Hospital (1) · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (1) · Zhujiang Hospital (1)
China (3)
Junfang Yang, Ph.D. (1) · Li Li, MD (1) · Li-hua Yang, Ph.D. (1) · Lung-Ji Chang, Ph.D. (1) · Sanbin Wang, Doctor (1)